Skip to content
HowShorted

Pernix Therapeutics Holdings, short interest in 2018

In 2018, Pernix Therapeutics Holdings,'s disclosed short interest ran from 18.46% of shares outstanding on 12 Jan 2018 to 16.46% on 31 Dec 2018, a change of -2.00 percentage points. The year's high was 21.03% on 15 Feb 2018 and its low 14.73% on 30 Nov 2018, averaging 17.68% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 58.28 days on 15 Jun 2018. Full history: Pernix Therapeutics Holdings,.

Cite this page
Plain
Wikipedia
BibTeX
Aggregate net short position time series for Pernix Therapeutics Holdings, in 2018

2018 in figures

Start of year
18.46% (12 Jan 2018)
End of year
16.46% (31 Dec 2018)
Change
-2.00 pp
High
21.03% (15 Feb 2018)
Low
14.73% (30 Nov 2018)
Average
17.68%
Highest days to cover
58.28 (15 Jun 2018)
SEC filings marked
8

Every report in 2018

Pernix Therapeutics Holdings, short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201818.46%13.50
31 Jan 201819.22%19.27
15 Feb 201821.03%23.31
28 Feb 201820.28%19.64
15 Mar 201819.31%10.0110-K filed, results (8-K)
29 Mar 201819.80%26.29
13 Apr 201819.77%44.89
30 Apr 201819.24%31.56
15 May 201818.72%38.4610-Q filed, results (8-K)
31 May 201818.17%22.21
15 Jun 201817.99%58.28
29 Jun 201817.84%45.08
13 Jul 201817.62%48.32
31 Jul 201817.41%52.18
15 Aug 201815.71%16.5810-Q filed, results (8-K)
31 Aug 201815.62%10.53
14 Sep 201815.85%5.75
28 Sep 201816.20%6.58
15 Oct 201816.69%14.29
31 Oct 201816.36%15.60
15 Nov 201815.46%20.9510-Q filed, results (8-K)
30 Nov 201814.73%13.62
14 Dec 201816.44%1.00
31 Dec 201816.46%6.15

See also: Pernix Therapeutics Holdings,'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.